OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Market Cap	186.52B -22.8%
Revenue (ttm)	14.22B -1.6%
Net Income	-738.03M
EPS	-6.44
Shares Out	114.65M
PE Ratio	n/a
Forward PE	39.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	713,622
Open	1,626.90
Previous Close	1,626.90
Day's Range	1,606.70 - 1,690.80
52-Week Range	1,057.00 - 2,088.00
Beta	n/a
Analysts	Buy
Price Target	2,036.75 (+21.74%)
Earnings Date	Jul 24, 2026

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,412
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONESOURCE

Financial Performance

In fiscal year 2026, NSE:ONESOURCE's revenue was 14.22 billion, a decrease of -1.61% compared to the previous year's 14.45 billion. Losses were -738.03 million, 310.7% more than in 2025.

Analyst Summary

According to 4 analysts, the average rating for ONESOURCE stock is "Buy." The 12-month stock price target is ₹2,037, which is an increase of 21.74% from the latest price.

Price Target

₹2,037

(21.74% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 13, 2026

Data Sources Report a data error